Stereotactic techniques for lung cancer treatment

Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC): Fourth Edition

Volumn , Issue , 2012, Pages 589-600

  Timmerman, Robert D ^a   Solberg, Timothy D ^b   Kavanagh, Brian D ^c,e   Lo, Simon S ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973412466     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (108)

1. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-319.
2. Murray B, Forster K, Timmerman R. Frame-based immobilization and targeting for stereotactic body radiation therapy. Med Dosim 2007;32:86-91.
3. Purdie TG, Bissonnette JP, Franks K, et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys2007;68:243-252.
4. Jaffray DA. Image-guided radiation therapy: from concept to practice. Semin Radiat Oncol 2007;17:243-244.
5. Franks KN, Bezjak A, Purdie TG, et al. Early results of image-guided radiation therapy in lung stereotactic body radiotherapy (SBRT). Clin Oncol (R Coll Radiol) 2007;19:S10.
6. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007;25:938-946.
7. Timmerman R, Papiez L, Suntharalingam M. Extracranial stereotactic radiation delivery: expansion of technology beyond the brain. Technol Cancer Res Treat 2003;2:153-160.
8. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004;60:1026-1032.
9. Potters L, Timmerman R, Larson D. Stereotactic body radiation therapy. J Am Coll Radiol 2005;2:676-680.
10. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796-801.
11. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196.
12. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2007;2:S 101-S112.
13. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-S100.
14. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys2005;63:1427-1431.
15. Fritz P, Kraus HJ, Blaschke T, et al. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Lung Cancer 2008;60:193-199.
16. Brown WT, Wu X, Wen BC, et al. Early results of Cyber Knife image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Comput Aided Surg 2007;12:253-261.
17. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol2006;45:787-795.
18. Timmerman R, Paulus R, Galvin J, et al. Toxicity Analysis of RTOG 0236 using stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients. Int J Radiat Oncol Biol Phys 2007;69:S86.
19. Hall EJ, Astor M, Bedford J, et al. Basic radiobiology. Am J Clin Oncol 1988;11:220-252.
20. Hamilton AJ, Lulu BA, Fosmire H, et al. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 1995;36:311-319.
21. Lax I. Target dose versus extratarget dose in stereotactic radiosurgery. Acta Oncol 1993;32:453-457.
22. Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-683.
23. Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
24. Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998;1:63-74.
25. Shirato H, Shimizu S, Shimizu T, et al. Real-time tumour-tracking radiotherapy. Lancet 1999;353:1331-1332.
26. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-1070.
27. Uematsu M, Shioda A, Suda A, et al. Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit. Int J Radiat Oncol Biol Phys 2000;48:443-448.
28. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-670.
29. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124: 1946-1955.
30. Hof H, Herfarth KK, Munter M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003;56:335-341.
31. Timmerman R, Galvin J, Michalski J, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol 2006;45:779-786.
32. Sloviter HA. The effect of complete ablation of thyroid tissue by radioactive iodine on the survival of tumor-bearing mice. Cancer Res 1951;11:447-449.
33. Allen HC Jr. Subtotal ablation of the thyroid gland with a single dose of radioactive Iodine-131 for the treatment of thyrotoxicosis. South Med J 1956;49:1428-1440.
34. Lippincott SW, Lewallen CG, Shellabarger CJ. Pathology of radioiso-topic ablation of the thyroid in the dog. AMA Arch Pathol 1957;63:540-556.
35. Storaasli JP, Schoeniger EL, Hellerstein HK, et al. Thyroid ablation with I-131 in euthyroid cardiac patients, with special reference to preparation with antithyroid drugs. Radiology 1960;74:810-815.
36. Goolden AW, Davey JB. The ablation of normal thyroid tissue with iodine 131. Br J Radiol 1963;36:340-345.
37. Alheit H, Dornfeld S, Dawel M, et al. Patient position reproducibility in fractionated stereotactically guided conformal radiotherapy using the BrainLab mask system. Strahlenther Onkol 2001;177:264-268.
38. Bale RJ, Sweeney R, Vogele M, et al. [Noninvasive head fixation for external irradiation of tumors of the head and neck area]. Strahlenther Onkol 1998;174:350-354.
39. Fairclough-Tompa L, Larsen T, Jaywant SM. Immobilization in stereotactic radiotherapy: the head and neck localizer frame. Med Dosim 2001;26:267-273.
40. Fuss M, Salter BJ, Rassiah P, et al. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy. Technol Cancer Res Treat 2004;3:59-67.
41. Herfarth KK, Debus J, Lohr F, et al. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 2000;46:329-335.
42. Hof H, Herfarth KK, Munter M, et al. The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation. Strahlenther Onkol 2003;179:542-547.
43. Lax I, Blomgren H, Larson D, et al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg 1998;1:135-148.
44. Lohr F, Debus J, Frank C, et al. Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:521-527.
45. Nagata Y, Negoro Y, Aoki T, et al. [Three-dimensional conformal radiotherapy for extracranial tumors using a stereotactic body frame]. Igaku Butsuri 2001;21:28-34.
46. Negoro Y, Nagata Y, Aoki T, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys 2001;50:889-898.
47. Nevinny-Stickel M, Sweeney RA, Bale RJ, et al. Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vacuum technique. Strahlenther Onkol 2004;180:117-122.
48. Takacs II, Kishan A, Deogaonkar M, et al. Respiration induced target drift in spinal stereotactic radiosurgery: evaluation of skeletal fixation in a porcine model. Stereotact Funct Neurosurg 1999;73:70.
49. Wulf J, Hädinger U, Oppitz U, et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000;57:225-236.
50. Wang LT, Solberg TD, Medin PM, et al. Infrared patient positioning for stereotactic radiosurgery of extracranial tumors. Comput Biol Med 2001;31:101-111.
51. Uematsu M, Sonderegger M, Shioda A, et al. Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker. Radiother Oncol 1999;50:337-339.
52. Takai Y, Mituya M, Nemoto K, et al. [Simple method of stereotactic radiotherapy without stereotactic body frame for extracranial tumors]. Nippon Igaku Hoshasen Gakkai Zasshi 2001;61:403-407.
53. Yin F, Kim JG, Haughton C, et al. Extracranial radiosurgery: immobilizing liver motion in dogs using high-frequency jet ventilation and total intravenous anesthesia. Int J Radiat Oncol Biol Phys 2001;49:211-216.
54. O'Dell WG, Schell MC, Reynolds D, et al. Dose broadening due to target position variability during fractionated breath-held radiation therapy. Med Phys 2002;29:1430-1437.
55. Murphy MJ, Martin D, Whyte R, et al. The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery. Int J Radiat Oncol Biol Phys 2002;53:475-482.
56. Kimura T, Hirokawa Y, Murakami Y, et al. Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1307-1313.
57. Vedam SS, Keall PJ, Kini VR, et al. Determining parameters for respiration-gated radiotherapy. Med Phys 2001;28:2139-2146.
58. Kini VR, Vedam SS, Keall PJ, et al. Patient training in respiratorygated radiotherapy. Med Dosim 2003;28:7-11.
59. Hara R, Itami J, Aruga T, et al. [Development of stereotactic irradiation system of body tumors under respiratory gating]. Nippon Igaku Hoshasen Gakkai Zasshi 2002;62:156-160.
60. Kitamura K, Shirato H, Seppenwoolde Y, et al. Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumortracking radiotherapy system. Int J Radiat Oncol Biol Phys 2003;56:221-228.
61. Kuriyama K, Onishi H, Sano N, et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys 2003;55:428-435.
62. Schweikard A, Shiomi H, Adler J. Respiration tracking in radiosurgery. Med Phys 2004;31:2738-2741.
63. Sharp GC, Jiang SB, Shimizu S, et al. Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol 2004;49:425-440.
64. Hall EJ, Gross W, Dvorak RF, et al. Survival curves and age response functions for Chinese hamster cells exposed to x-rays or high LET alpha-particles. Radiat Res 1972;52:88-98.
65. Kellerer AM, Rossi HH. Dependence of RBE on neutron dose. Br J Radiol 1972;45:626.
66. Rossi HH, Kellerer AM. Radiation carcinogenesis at low doses. Science 1972;175:200-202.
67. Park C, Papiez L, Zhang S, et al. The universal survival curve and single fraction equivalent dose: useful tools in understanding the potency of ablative radiation therapy. Int J Radiat Oncol Biol Phys 2008 1;70(3):847-852.
68. Marks LB. Extrapolating hypofractionated radiation schemes from radiosurgery data: regarding Hall et al., IJROBP 21:819-824; 1991 and Hall and Brenner, IJROBP 25:381-385; 1993. Int J Radiat Oncol Biol Phys 1995;32:274-276.
69. Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004;49:4825-4835.
70. Hall EJ. Radiobiology for the Radiologist. 2nd Ed. Philadelphia, PA: Harper & Row Publishers, 1978.
71. Benedict SH, Lin PS, Zwicker RD, et al. The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1997;37:765-769.
72. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004;59:242-249.
73. Yaes RJ, Kalend A. Local stem cell depletion model for radiation myelitis. Int J Radiat Oncol Biol Phys 1988;14:1247-1259.
74. Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 1982;8:1761-1769.
75. Cardinale RM, Wu Q, Benedict SH, et al. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:515-520.
76. Liu R, Buatti JM, Howes TL, et al. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys 2006;66:906-912.
77. Papiez L, Timmerman R, DesRosiers C, et al. Extracranial stereotactic radioablation: physical principles. Acta Oncol 2003;42:882-894.
78. Papiez L. On the equivalence of rotational and concentric therapy. Phys Med Biol 2000;45:399-409.
79. Hadinger U, Thiele W, Wulf J. Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformity. Z Med Phys 2002;12:221-229.
80. Traberg Hansen A, Petersen JB, Høyer M, et al. Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning. Radiother Oncol 2005;77:96-98.
81. Ding GX, Duggan DM, Lu B, et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 2007;34:2985-2994.
82. Mayer R, Williams A, Frankel T, et al. Two-dimensional film dosimetry application in heterogeneous materials exposed to megavoltage photon beams. Med Phys 1997;24:455-460.
83. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015.
84. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70:1057-1065.
85. Matsuo Y, Nagata Y, Mizowaki T, et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007;12:356-362.
86. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839.
87. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107-114.
88. Nyman J, Johansson KA, Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 2006;51:97-103.
89. Fritz P, Kraus HJ, Muhlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 2006;1:30.
90. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-87.
91. Matsuo Y, Takayama K, Nagata Y, et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2007;68:416-425.
92. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631.
93. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
94. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-622; discussion 622-623.
95. Timmerman RD, Story M. Stereotactic body radiation therapy: a treatment in need of basic biological research. Cancer J 2006;12:19-20.
96. Timmerman R, Papiez L, Review of Song, et al. Stereotactic body radiation therapy: rationale, techniques, applications, and optimization of an emerging technology. Oncology 2004;18:474-477.
97. Song W, Schaly B, Bauman G, et al. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate. Med Phys 2005;32:2193-2203.
98. Martinez AA, Yan D, Lockman D, et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1226-1234.
99. Bortfeld T, Paganetti H. The biologic relevance of daily dose variations in adaptive treatment planning. Int J Radiat Oncol Biol Phys 2006;65:899-906.
100. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med2006;355:570-580.
101. Yan D, Lockman D, Brabbins D, et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:289-302.
102. Wu C, Jeraj R, Olivera GH, et al. Re-optimization in adaptive radiotherapy. Phys Med Biol 2002;47:3181-3195.
103. Brahme A. Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging. Acta Oncol 2003;42:123-136.
104. Pennathur A, Luketich JD, Burton S, et al. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience. Ann Thorac Surg 2007;83:1820-1824; discussion 1824-1825.
105. Hof H, Muenter M, Oetzel D, et al. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 2007;110:148-155.
106. Koto M, Takai Y, Ogawa Y, et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2007;85:429-434.
107. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;66:117-125.
108. Hara R, Itami J, Kondo T, et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 2006;106:1347-1352.